2025 Annual Report of Independent Director
Dear shareholders and shareholder representatives:
As an independent director of Guangdong Meilian New Materials Co., Ltd. (hereinafter referred to as "the Company"), I have strictly adhered to the provisions of the Company Law of the People's Republic of China, the Management Measures for Independent Directors of Listed Companies, and other relevant laws and regulations, as well as the Company’s Articles of Association and Independent Director Work System. I have diligently fulfilled my duties, actively attended all board and shareholder meetings, carefully reviewed various proposals, and provided independent, objective, and professional opinions to effectively safeguard the interests of the Company and its shareholders. Below is my report on the performance of my duties as an independent director during the year 2025:
I. Basic Information
Shen Yiyong, born in 1966, Chinese nationality, without permanent residency abroad, holds a Master of Laws. Since June 1989, I have been employed at Shantou University, currently serving as an associate professor and master's supervisor. I also hold positions as the vice-chairman of the Shantou Social Science Workers Association and an arbitrator for the Shantou Arbitration Commission. From October 2021 to present, I have served as an external director of Guangdong Shantou Ultrasonic Electronics Co., Ltd.; from May 2023 to present, as an independent director of Zhongyeda Electric Co., Ltd.; from February 2024 to present, as an independent director of Guangdong Taienkang Pharmaceutical Co., Ltd.; and from January 2025 to present, as an independent director of the Company. My qualifications meet the independence requirements stipulated in Article 6 of the Management Measures for Independent Directors of Listed Companies, and there are no circumstances affecting my independence.
II. Annual Performance Overview
During the reporting period, I actively participated in all board and shareholder meetings that I was required to attend, diligently reviewing meeting proposals and related materials, engaging in discussions, and providing reasonable suggestions, thereby contributing positively to the board's correct and scientific decision-making. In 2025, the convening of the board and shareholder meetings complied with legal procedures, and significant operational decisions and other major matters followed the relevant approval processes. My attendance at meetings is as follows:
(1) Attendance at Shareholder Meetings
During the reporting period, the Company held 6 shareholder meetings, and I was required to attend 5 of them, all of which I attended in person or via communication.
(2) Attendance at Board Meetings
During the reporting period, the Company held 10 board meetings, and I was required to attend 9 of them, all of which I attended in person or via communication. The specific attendance details are as follows:
| Name | Required Attendance | In-Person Attendance | Proxy Attendance | Absences | Consecutive Absences |
|---|---|---|---|---|---|
| Shen Yiyong | 9 | 9 | 0 | 0 | No |
During the reporting period, I voted in favor of all proposals submitted at each board meeting after careful review, with no objections or abstentions, and did not raise any dissenting opinions on any matters of the Company.